
Shares of surgical implants maker Paragon 28 FNA.N rise ~9.5% to $13.14 premarket
Medical device maker Zimmer Biomet ZBH.N said late on Tuesday it will acquire Paragon 28 for about $1.1 billion
The deal will give Zimmer access to Paragon's surgical implants and equipment used to treat foot and ankle ailments
Brokerage Truist says the deal makes "strategic sense" for Zimmer as "foot and ankle" is a faster growing subsegment of the orthopedic market
Zimmer will make an upfront payment of $13.00/shr in cash, which represents an 8.3% premium to Paragon's closing price on Tuesday
Up to last close, stock down 2.3% in the last 12 months